276 related articles for article (PubMed ID: 6189604)
1. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
Miller LP; Miller DR; Tan CT
Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
[No Abstract] [Full Text] [Related]
2. Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group.
Winton EF; Hearn EB; Martelo O; Presant CA; Adler S; Vogler WR; Raney M; Logan T; Silberman HM; Omura GA
Cancer Treat Rep; 1985; 69(7-8):807-11. PubMed ID: 2410119
[TBL] [Abstract][Full Text] [Related]
3. [Clinical activity of m-Amsa and the combination of m-Amsa with cytosine arabinoside].
Weil M; Auclerc MF; Schaison G; Auclerc G; Daubrisson A; Degos L; Caro J; Marty M; Jacquillat GI
Nouv Presse Med; 1982 Oct; 11(39):2911-4. PubMed ID: 6755389
[TBL] [Abstract][Full Text] [Related]
4. Current status of amsacrine (AMSA) combination chemotherapy programs in acute leukemia.
Arlin ZA
Cancer Treat Rep; 1983 Nov; 67(11):967-70. PubMed ID: 6357436
[No Abstract] [Full Text] [Related]
5. [Treatment of acute myeloid leukemia with amsacrine and high-dose cytosine arabinoside: a phase II trial].
Marit G; David B; Reiffers J; Broustet A
Bull Cancer; 1985; 72(1):37-41. PubMed ID: 3857082
[TBL] [Abstract][Full Text] [Related]
6. Cyclocytidine in the treatment of refractory acute childhood leukemia: a Southwest Oncology Group Phase I-II study.
Miale T; Hvizdala E; Ragab A; Pullen J; O'Brien P; McMillan C
Cancer Treat Rep; 1979; 63(11-12):1913-5. PubMed ID: 93513
[TBL] [Abstract][Full Text] [Related]
7. Amsacrine in refractory acute leukemia.
Griffin JD; Maguire ME; Mayer RJ
Cancer Treat Rep; 1985; 69(7-8):787-9. PubMed ID: 3860296
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cyclocytidine in children with advanced acute leukemia and solid tumors.
Finklestein JZ; Higgins G; Krivit W; Hammond D
Cancer Treat Rep; 1979 Aug; 63(8):1331-3. PubMed ID: 89907
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of amsacrine gluconate in refractory leukemia.
Omura GA; Winton EF; Vogler WR; Zuckerman KS; Grillo-Lopez AJ
Cancer Treat Rep; 1983 Dec; 67(12):1131-2. PubMed ID: 6580948
[TBL] [Abstract][Full Text] [Related]
10. m-AMSA: phase II trial in advanced lymphoma and leukemia.
Case DC
Am J Clin Oncol; 1984 Aug; 7(4):357-60. PubMed ID: 6588746
[TBL] [Abstract][Full Text] [Related]
11. Acute electrocardiographic changes induced by amsacrine.
Shinar E; Hasin Y
Cancer Treat Rep; 1984 Sep; 68(9):1169-72. PubMed ID: 6592038
[TBL] [Abstract][Full Text] [Related]
12. Acridinyl anisidide (m-AMSA) therapy in 11 patients with refractory acute leukemia.
Naparstek E; Shinar E; Polliack A
Isr J Med Sci; 1984 Feb; 20(2):118-22. PubMed ID: 6546740
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of combination chemotherapy with etoposide and amsacrine in relapsed adult leukemia.
Abrams RA; Hanson G; Hansen RM; Anderson T
Cancer Treat Rep; 1986 Apr; 70(4):535. PubMed ID: 3754490
[No Abstract] [Full Text] [Related]
14. High-dose amsacrine (AMSA) therapy of relapsed and refractory adult acute nonlymphocytic leukemia. A phase II study.
Cassileth PA; Lyman GH; Bennett JM; Glick JH; Oken MM
Am J Clin Oncol; 1984 Aug; 7(4):361-3. PubMed ID: 6547566
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study.
Amrein PC; Richards F; Coleman M; Poulin RF; Holland JF; Weinberg V; Perry M
Cancer Treat Rep; 1984 Jun; 68(6):923-4. PubMed ID: 6329510
[No Abstract] [Full Text] [Related]
16. Amsacrine in refractory adult acute leukemia: a pilot study of the Southeastern Cancer Study Group.
Winton EF; Hearn EB; Vogler WR; Johnson L; Logan T; Raney M
Cancer Treat Rep; 1983 Nov; 67(11):977-80. PubMed ID: 6580070
[TBL] [Abstract][Full Text] [Related]
17. Amsacrine (AMSA)--a clinical review.
Louie AC; Issell BF
J Clin Oncol; 1985 Apr; 3(4):562-92. PubMed ID: 3884748
[No Abstract] [Full Text] [Related]
18. [Phase II study of AMSA in adults with acute therapy-refractory leukemias].
Fiebig HH; Henss H; Engelhardt R; Hoelzer D; Pralle H; Link H; Schmitz R
Onkologie; 1983 Aug; 6(4):188-90. PubMed ID: 6355948
[TBL] [Abstract][Full Text] [Related]
19. [A case of hypoplastic leukemia in advanced age induced into complete remission with continuous drip infusion of cyclocytidine and prednisolone (author's transl)].
Wakiya I; Ban S; Ishii Y; Yagiri Y; Miyake Y
Rinsho Ketsueki; 1982 Feb; 23(2):180-4. PubMed ID: 6178859
[No Abstract] [Full Text] [Related]
20. [Chemotherapy of acute leukemia with cyclocytidine, with special reference to serum ara-C deaminase activity (author's transl)].
Nakamura T; Sasada M; Sawada H; Higuchi T; Tatsumi K
Nihon Ketsueki Gakkai Zasshi; 1977 Jun; 40(3):293-9. PubMed ID: 72473
[No Abstract] [Full Text] [Related]
[Next] [New Search]
